Solventum (SOLV), the healthcare company spun off from 3M (MMM) earlier this year, has retained bankers to explore a sale of its purification and filtration business, people familiar with the matter told The Wall Street Journal’s Lauren Thomas. Solventum is expected to draw takeover interest from private equity and strategic buyers, the sources said.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SOLV:
Questions or Comments about the article? Write to editor@tipranks.com